米非司酮对子宫内膜异位症的治疗价值评析

Evaluation of mifepristone in the treatment of endometriosis

目的分析米非司酮对子宫内膜异位症的治疗价值。方法将2016年1月-2016年10月160例子宫内膜异位症患者根据数字随机表法分两组各80例。常规组治疗采取孕三烯酮,研究组治疗采取米非司酮。比较两组子宫内膜异位症疗效;不良反应;干预前后患者子宫内膜厚度、激素指标。结果研究组子宫内膜异位症疗效高于常规组,差异有统计学意义（P〈0.05）;研究组不良反应低于常规组,差异有统计学意义（P〈0.05）;干预前两组子宫内膜厚度、激素指标相近,差异无统计学意义（P〉0.05）;出院时研究组子宫内膜厚度、激素指标优于常规组,差异有统计学意义（P〈0.05）。结论米非司酮对子宫内膜异位症的治疗价值高,可改善子宫内膜厚度、激素,减少不良反应,安全有效。

Objective To analyze the therapeutic value of mifepristone in endometriosis.Methods 160 patients with endometriosis from January 2016 to October 2016 were divided into two groups according to the number randomized table method.The conventional group was treated with gestrinone and the study group treated with mifepristone.Comparison of two groups of endometriosis effcacy;adverse reactions;before and after treatment of patients with endometrial thickness,hormone indicators. Results The curative effect of endometriosis was higher in the study group than that in the conventional group （P〈0.05）.The adverse effects of the study group were lower than those of the conventional group （P〈0.05）.At the time of discharge, the endometrial thickness and hormone index of the study group were better than those of the conventional group,（P〈0.05）. Conclusion Mifepristone has a high therapeutic value for endometriosis, which can improve endometrial thickness,hormone and reduce adverse reactions,safe and effective.